## Abstract The highly potent serotonin (5βHT) uptake blocker, McNβ5652βZ (__trans__β1,2,3,5,6,10b β hexahydro β 6 β [4 β (methylthio)phenyl] pyrrolo β [2,1βa]βisoquinoline) was labeled with ^11^C for studying serotonin uptake sites using positron emission tomography (PET). [^11^C]McNβ5652βZ was sy
β¦ LIBER β¦
Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with [11C]McN
β Scribed by Justine M. Kent; Jeremy D. Coplan; Ilise Lombardo; Dah-Ren Hwang; Yiyun Huang; Osama Mawlawi; Ronald L. Van Heertum; Mark Slifstein; Anissa Abi-Dargham; Jack M. Gorman; Marc Laruelle
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 211 KB
- Volume
- 164
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Synthesis of a radiotracer for studying
β
Makiko Suehiro; Hayden T. Ravert; Robert F. Dannals; Ursula Scheffel; Henry N. W
π
Article
π
1992
π
John Wiley and Sons
π
French
β 422 KB
Serotonin transporter occupancy of high-
β
Aristotle N. Voineskos; Alan A. Wilson; Anahita Boovariwala; Sandra Sagrati; Syl
π
Article
π
2007
π
Springer
π
English
β 155 KB
Diminished brain 5-HT transporter bindin
β
Sudhakar Selvaraj; Naga Venkatesha Murthy; Zubin Bhagwagar; Subrata K. Bose; Rai
π
Article
π
2009
π
Springer
π
English
β 226 KB
Serotonin 1A receptor availability in pa
β
W. Gordon Frankle; Ilise Lombardo; Lawrence S. Kegeles; Mark Slifstein; John H.
π
Article
π
2006
π
Springer
π
English
β 209 KB
A positron emission tomography (PET) stu
β
Y. Hodé; M. Reimold; A. Demazières; G. Reischl; F. Bayle; P. Nuss; A. Hameg; M.
π
Article
π
2005
π
Springer
π
English
β 160 KB
Long-term changes of striatal dopamine D
β
Angelo Antonini; Johannes Schwarz; Wolfgang H. Oertel; Oliver Pogarell; Prof. Kl
π
Article
π
1997
π
John Wiley and Sons
π
English
β 574 KB
## Abstract We used [^11^C]raclopride (RACLO) and positron emission tomography (PET) to study longitudinally striatal dopamine D~2~ receptor binding in nine patients with Parkinson's disease (PD) at an early drugβnaive stage and 3β5 years later, when motor fluctuations had appeared in seven of them